Patrick Ho
Conseiller Juridique Général chez Apple Tree venture Managemnet Llc//vc
Profil
Patrick Ho is associate general counsel for ATP.
Prior to ATP, he was associate general counsel and director of Business Development at IAVI, a global health R&D organization.
His previous experience also includes co-founding and managing legal affairs and business operations at Vaxess Technologies, a life science company developing novel vaccine and therapeutic delivery technologies, and practicing IP litigation as an associate with Quinn Emanuel Urquhart & Sullivan.
He received an AB in physics from Princeton University and a JD from Harvard Law School.
Postes actifs de Patrick Ho
Sociétés | Poste | Début |
---|---|---|
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Conseiller Juridique Général | 01/06/2021 |
Anciens postes connus de Patrick Ho
Sociétés | Poste | Fin |
---|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Conseiller Juridique Général | 01/06/2021 |
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Fondateur | - |
Formation de Patrick Ho
Harvard Law School | Graduate Degree |
Princeton University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Vaxess Technologies, Inc.
Vaxess Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Vaxess Technologies, Inc. provides global vaccine access distribution services. It develops a pipeline of next-generation MIMIX therapies. The firm provides MIMIX oncology and MIMIX infectious disease. The company was founded by Patrick Ho, David Kaplan, Kathryn Kosuda, Fiorenzo Omenetto, Michael Schrader and Livio Valenti in 2012 and is headquartered in Cambridge, MA. | Commercial Services |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |